comparemela.com

Latest Breaking News On - Biologic therapy - Page 3 : comparemela.com

FDA Approves Second Gene Therapy for Hemophilia B

Pfizer reported a list price of $3.5 million for its new gene therapy, Beqvez, for adults with this rare bleeding disorder.

Drug administrationHemophilia haemophiliaBiologic therapyGenomics genomic medicineGene therapyHemophiliab haemophilia bHemophiliaa haemophilia aLiver enzymesLiver studiesUs food and drug administrationNited states food and drug administration

When to Switch a Drug Class in Psoriasis Treatment

Experts conclude the series discussing how to approach switching psoriasis treatments.

Biologic therapyMoral therapyShared decision making

Exploring Innovation: Recent Approvals and Novel Approaches to Psoriasis Treatment

Experts discuss bimekizumab for the treatment of psoriasis highlighting is efficacy over other treatments.

Biologic therapyMoral therapyShared decision makingLiver enzymes

Two Biosimilars Approved in Europe for Autoimmune Disorders

The drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's disease.

United statesEuropean unionMedicinal productsHuman useEuropean medicines agencyRheumatoid arthritis raHeumatoid arthritis raPsoriatic arthritisRthropathic psoriasisPsoriatic arthropathyOint inflammationJuvenile rheumatoid arthritisUvenile raJuvenile idiopathic arthritisCrohn 039s diseaseCrohn disease

Timing Is Everything: CAR T for Follicular Lymphoma

CAR T-cell therapy is the best option for patients with relapsed/refractory follicular lymphoma, even though it comes with serious side effects.

United statesDana farber cancer instituteNew yorkCaron jacobsonPeter martinCharalambos babis andreadisGreat debatesUpdates hematologic malignanciesNew york cityKite pharmaNewyork presbyterian hospitalWeill cornell medicineCart cellCalifornia san franciscoHelen diller family comprehensive careNon hodgkin 039s lymphoma

vimarsana © 2020. All Rights Reserved.